Key result
Higher HRV, sleep efficiency, and daily steps are linked to lower daily mean glucose.
Why the study?
Integrating CGM data with wearable signals may clarify how glucose interacts with sleep, activity, and cardiovascular physiology, leading the authors to characterize these associations and evaluate multimodal wearable data.
Are wearable physiological signals (HR, HRV, sleep, activity) associated with continuous glucose monitor metrics in adults without diabetes?
Observational (n=46,033)
Are wearable physiological signals (HR, HRV, sleep, activity) associated with continuous glucose monitor metrics in adults without diabetes?
Wearable physiological metrics such as HRV, sleep efficiency, and step count correlate with continuous glucose monitor data in adults without diabetes, suggesting utility for scalable metabolic health assessment.
Answers are grounded in this paper and cite their sources.
Associations support wearable metabolic monitoring in non-diabetics; leaves open causal links and clinical utility.
Introduction and Objective: The use of continuous glucose monitors (CGMs) has expanded to people without diabetes, offering actionable insights that support healthy behavior and lifestyle change. Integrating CGM data with other wearable signals may clarify how glucose interacts with sleep, activity, and cardiovascular physiology. We sought to characterize these associations and evaluate the utility of multimodal wearable data. Methods: We analyzed de-identified data from 46,033 adults (67% female, age range 18-90), who wore an Oura Ring and used a Dexcom Stelo glucose biosensor for at least 7 days, for a total of 1,353,416 days. Outcomes were daily mean glucose, glucose variability (coefficient of variation, CV), and time above range >140 mg/dL (TAR). Oura Ring metrics included nighttime heart rate (HR), heart-rate variability (HRV), cardiovascular age (CVA), sleep duration and efficiency, activity (steps). We modeled these associations using cubic B-spline regressions adjusted for age, sex, and BMI. Results: The median daily mean glucose in the sample was 109 mg/dL, median CV 12.7%, median TAR 55 min. Higher HRV, sleep efficiency, and more steps per day were associated with lower glucose (Fig 1). Conversely, higher HR and CVA were associated with higher glucose. Conclusion: Oura physiological metrics show associations with glucose biosensor data, supporting the utility of research for their use in scalable metabolic health assessment and interventions. Disclosure A. Kluge: Employee; Current; Oura Health Oy. M. Karsikas: Employee; Current; Oura Health. T. Kinnunen: Employee; Current; Oura Health Oy. P. Ohukainen: Employee; Current; Oura Health oy.
No takes yet. Share an insight, caveat, or question.
KLUGE et al. (2026) conducted an observational in Without self-reported diabetes (n=46,033). Oura Ring physiological metrics (HR, HRV, CVA, sleep, activity) was evaluated on Daily mean glucose, glucose variability (CV), and time above range >140 mg/dL (TAR). Higher heart-rate variability, sleep efficiency, and daily steps were associated with lower glucose, while higher heart rate and cardiovascular age were associated with higher glucose.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: